Jasper Therapeutics, Inc. — NT 10-Q Filings
1 NT 10-Q filing on record
This page lists all NT 10-Q filings submitted to the SEC by Jasper Therapeutics, Inc. (JSPRW), sorted by most recent first. Each row links to the full filing on EdgarLookup. Jasper Therapeutics, Inc. has filed 1 NT 10-Q document with the SEC since 2019. To view all SEC filings by Jasper Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
25-NSE
3
3/A
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
NT 10-Q
POS AM
PRE 14A
S-1
S-1/A
S-3
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| NT 10-Q | NOTIFICATION OF LATE FILING | 0001213900-21-027633 | May 18, 2021 | Mar 31, 2021 |